12/05/2017 6o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | N.Bouboulis | 3. Unanimous verdict: non TF patient but requires TAVR. Access selection path

 
876 VIEWS EXPANDCOLLAPSE PRESENTATION

Share

167,109 total
535 live
876 video
76,228 photo
Views:

11:30-13:30 TAVR club I
Πρόεδροι: G.Sianos,I.Mastorakou,I.Chlorogiannis,A.Dimas
11:30-11:45 1. MSCT screening. Guidance, device selection, and outcomes prediction
C.Mourmouris
11:45-12:00 2. TF access today: vessel, device and experience related minimum requirements, limits, techniques
G.Latsios
12:00-12:15 3. Unanimous verdict: non TF patient but requires TAVR. Access selection path
N.Bouboulis
12:15-12:30 4. Concomitant coronary artery disease: significance and an individualized treatment approach
V.Tzifos
12:30-12:45 5. The advanced renal failure and the on renal replacement patient. Planning, techniques, device selection, valve durability and other issues
E.Skalidis
12:45-13:00 6. The procedure was flawless but unfortunately the patient never made it to home. Why and how to avoid this in the future
K.Toutouzas
13:00-13:20 7. TAVR live-in-a-box
K.Spargias
13:20-13:30 Συζήτηση


 
Sort by Date | Views
Watch live and on demand the '6th Conference of  Transcatheter Heart Valve Therapies'.
​
The Diagnostic and Therapeutic Center of Athens Hygeia organizes the '6th Conference of  Transcatheter Heart Valve Therapies' that will take place from 12 to 13 May 2017, at Hilton Hotel in Athens, Greece.

For more information please click here.

Παρακολουθήστε ζωντανά και on demand το '6ο Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών'.

Το Διαγνωστικό Θεραπευτικό Κέντρο Αθηνών ΥΓΕΙΑ διοργανώνει το '6o Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών' στις 12 - 13 Μαΐου 2017 στο ξενοδοχείο Hilton στην Αθήνα.

Για περισσότερες πληροφορίες, πατήστε εδώ.
A.Manginas | 1. The foundation of a new... 1.042
K.Spargias | 2. TAVR: The device evolution... 1.121
K.Toutouzas | 3. TAVR: The constantly changing... 955
G.Latsios | 4. What is the reasonable training... 1.050
K.Bellos | 5. What is the reasonable training... 984
A.Manolis | 6. Who should be performing... 1.680
I.Iakovou | 7. TAVI live case-in-a-box 1.189
S.Pattakos 917
460
D.Cokkinos 1.084
A.Kartapanis 908
I.Goudevenos 935
Στρατής Παττακός | Καρδιοχειρουργός, Διευθυντής... 1.168
1:24
Στέφανος Φούσας | Σ. Διευθυντής - Ε. Καθηγητής... 822
2:31
C.Mourmouris | 1. MSCT screening. Guidance,... 894
Catherine Avgeropoulou, Cardiologist, Director,... 967
1:49
Konstantinos Toutouzas | Associate Professor... 1.214
2:08
G.Latsios | 2. TF access today: vessel,... 873
Gregory Pavlides | MD, PhD, FACC, FESC, Professor... 988
2:08
N.Bouboulis | 3. Unanimous verdict: non... 876
V.Tzifos | 4. Concomitant coronary artery... 891
E.Skalidis | 5. The advanced renal failure... 995
K.Toutouzas | 6. The procedure was flawless... 958
K.Spargias | 7. TAVR live-in-a-box 977
C.Avgeropoulou | 1. A “Physiologist’s” view... 1.053
C.Chrysohoou | 2. From clinical practice... 1.009
G.Makos | 4. MR Surgery. When to repair... 1.005
G.Pavlides | 5. Trancatheter MV replacement.... 960
K.Spargias | 6. MAC and ViV, ViR 914
K.Spargias | 7. Mitraclip case-in-a-box 1.036
K.Spargias | 1. The “standardized” TAVR... 785
Konstantinos Spargias | Director, Transcatheter... 1.347
1:56
George Dangas | FESC, FACC, Professor of... 981
2:10
L.Papavasileiou | 2. Pacemaker need after... 906
A.Kostopoulou | 3. Pacemaker indication:... 1.131
J.Velianou | 4. Why I want to move to lower... 938
V. Andoutsopoulou | 5. What bothers me to... 1.198
G.Dangas | 6. Antiplatelet/anticoagulation... 1.026
C.Arampatzis | 7. My best and worst TAVR... 900
K.Raisakis | 1. My best and worst TAVR case... 1.054
V.Tzifos | 2. My best and worst TAVR case... 980
P.Davlouros | 3. My best and worst TAVR... 1.035
M.Ηamilos | 4. My best and worst TAVR case... 753
A.Zacharoulis | 5. My best and worst TAVR... 860
A.Synetos | 6. My best and worst TAVR case... 1.054
K.Papadopoulos | 8. My best and worst TAVR... 977
Andreas Synetos | MD, PhD, FESC, Cardiologist,... 1.000
1:24
V.Ninios | 1. MitraClip patient selection-... 967
V.Ninios | 1. MitraClip patient selection-... 915
G.Pavlides | 3. Mitral interventions: a... 948
S.Pattakos | 6. Which “operable” DMR patient... 916
V.Ninios | 7. Mitraclip case-in-a-box 797
M.Vavouranakis | 1. How I select my TAVR... 905
K.Spargias | 2. How I select my TAVR device?... 882
D.Nikas | 4. How I select my TAVR device?... 881
D.Nikas | 4. How I select my TAVR device?... 671
Q&A / Comments 870
K. Papadopoulos - K.Spargias | 6. TAVR live-in-a-box 930
A.Gkouziouta | 1. The pathophysiology of... 1.044
I.Ikonomidis | 2. Assessing Tricuspid Regurgitation:... 1.003
P.Sfyridis | 3. The unforgotten valve: what... 868
V.Sachpekidis | 5. The multiple valve disease... 981
V.Ninios | 6. Mitraclip in TR 841
M.Chrissoheris | 7. FORMA in TR 944
G.Stavridis | 8. The isolated TR inoperable... 962
Q&A / Comments 948
VIDEO UNDER EDITING - L.Michalis | 1. TAVR:... 1.008
D.Angouras | 2. TAVR device durability.... 967
L.Poulimenos | 3. Paradox AVS: implications... 1.093
P.Dardas | 4. TAVR in Bicuspid and ViV 868
I.Iakovou | 5. VARC-2 and MVRC definitions 982
G.Bompas | 6. The concept of 4D imaging... 976
D.Nikas | 7. My best and worst TAVR case... 776
A.Ziakas | 3. My best and worst TAVR case... 1.044
N.Pilatis | 1. My best and worst TAVR case... 750
G.Karavolias | 4. My best and worst TAVR... 963
K.Kalogeras | 5. My best and worst TAVR... 708
D.Tsikaderis | 6. My best and worst TAVR... 997
A.Manginas | 7. My best and worst TAVR case... 967
P. Kourkoveli | 2. My best and worst TAVR... 956
Christina Chrysohoou, MD, Cardiologist,Heart... 874
49
Irene Mastorakou, Cardiac Radiologist,Director,... 816
123
Lampros Michalis, Professor of Cardiology,University... 1.093
49
James Velianou, MD, FRCPC,Interventional... 955
69
Georgios Katsimagklis, InterventionalCardiologist,... 1.199
109